| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| BlackRock Inc. reports a 11.8% stake in VANDA PHARMACEUTICALS INC |
| 08/23/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,724 shares
@ $5.84, valued at
$21.7k
|
|
| 08/21/2023 |
8-K
| Other Events Interactive Data |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 6,500 shares
@ $6.0537, valued at
$39.3k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
8-K
| Quarterly results |
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Ward Anne Sempowski (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Honore Tage (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| DUGAN RICHARD W (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/08/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/17/2023 |
4
| Honore Tage (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 26,408 shares
@ $0
Granted 51,276 options to buy
@ $6.39, valued at
$327.7k
|
|
| 03/17/2023 |
3
| Honore Tage (Director) has filed a Form 3 on Vanda Pharmaceuticals Inc. |
| 03/17/2023 |
8-K
| Appointed a new director |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/06/2023 |
4
| Williams Timothy (SVP & General Counsel) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 8,437 shares
@ $6.2445, valued at
$52.7k
Sold 8,301 shares
@ $6.2507, valued at
$51.9k
|
|
| 03/06/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 7,720 shares
@ $6.2335, valued at
$48.1k
Sold 4,113 shares
@ $6.32, valued at
$26k
|
|
| 03/06/2023 |
4
| Polymeropoulos Mihael Hristos (President and CEO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 22,426 shares
@ $6.2302, valued at
$139.7k
Sold 22,538 shares
@ $6.2506, valued at
$140.9k
|
|
| 03/06/2023 |
4
| Moran Kevin Patrick (SVP, CFO & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 7,966 shares
@ $6.2573, valued at
$49.8k
Sold 5,968 shares
@ $6.2833, valued at
$37.5k
|
|
| 03/06/2023 |
4
| Birznieks Gunther (SVP, Business Development) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 8,509 shares
@ $6.2044, valued at
$52.8k
Sold 8,268 shares
@ $6.264, valued at
$51.8k
|
|
|